nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CHRM5—eye—autistic disorder	0.0156	0.0612	CbGeAlD
Darifenacin—CHRM4—head—autistic disorder	0.0113	0.0444	CbGeAlD
Darifenacin—CHRM4—nervous system—autistic disorder	0.0107	0.0421	CbGeAlD
Darifenacin—CHRM2—forebrain—autistic disorder	0.0106	0.0416	CbGeAlD
Darifenacin—CHRM4—central nervous system—autistic disorder	0.0103	0.0406	CbGeAlD
Darifenacin—CHRM2—telencephalon—autistic disorder	0.00975	0.0383	CbGeAlD
Darifenacin—CHRM1—forebrain—autistic disorder	0.00965	0.0379	CbGeAlD
Darifenacin—Difenoxin—OPRM1—autistic disorder	0.00904	0.206	CrCbGaD
Darifenacin—CHRM1—telencephalon—autistic disorder	0.00887	0.0349	CbGeAlD
Darifenacin—CHRM5—head—autistic disorder	0.00884	0.0347	CbGeAlD
Darifenacin—Anileridine—OPRM1—autistic disorder	0.00881	0.201	CrCbGaD
Darifenacin—CHRM3—forebrain—autistic disorder	0.00863	0.0339	CbGeAlD
Darifenacin—CYP2D6—hindbrain—autistic disorder	0.00844	0.0332	CbGeAlD
Darifenacin—CHRM5—nervous system—autistic disorder	0.00838	0.0329	CbGeAlD
Darifenacin—CHRM4—brain—autistic disorder	0.0082	0.0322	CbGeAlD
Darifenacin—CHRM5—central nervous system—autistic disorder	0.00807	0.0317	CbGeAlD
Darifenacin—CHRM3—telencephalon—autistic disorder	0.00794	0.0312	CbGeAlD
Darifenacin—CHRM5—brain—autistic disorder	0.00641	0.0252	CbGeAlD
Darifenacin—Diphenoxylate—OPRM1—autistic disorder	0.00637	0.145	CrCbGaD
Darifenacin—Loperamide—POMC—autistic disorder	0.00613	0.14	CrCbGaD
Darifenacin—CHRM2—head—autistic disorder	0.00607	0.0238	CbGeAlD
Darifenacin—CHRM3—digestive system—autistic disorder	0.00606	0.0238	CbGeAlD
Darifenacin—CHRM2—nervous system—autistic disorder	0.00575	0.0226	CbGeAlD
Darifenacin—CHRM2—central nervous system—autistic disorder	0.00554	0.0218	CbGeAlD
Darifenacin—CHRM1—head—autistic disorder	0.00552	0.0217	CbGeAlD
Darifenacin—CHRM1—nervous system—autistic disorder	0.00524	0.0206	CbGeAlD
Darifenacin—CHRM1—central nervous system—autistic disorder	0.00504	0.0198	CbGeAlD
Darifenacin—CHRM3—head—autistic disorder	0.00494	0.0194	CbGeAlD
Darifenacin—CYP2D6—brainstem—autistic disorder	0.00484	0.019	CbGeAlD
Darifenacin—CHRM3—nervous system—autistic disorder	0.00469	0.0184	CbGeAlD
Darifenacin—CYP2D6—forebrain—autistic disorder	0.00467	0.0183	CbGeAlD
Darifenacin—CHRM3—central nervous system—autistic disorder	0.00451	0.0177	CbGeAlD
Darifenacin—CHRM2—brain—autistic disorder	0.0044	0.0173	CbGeAlD
Darifenacin—CYP2D6—telencephalon—autistic disorder	0.00429	0.0169	CbGeAlD
Darifenacin—CHRM1—brain—autistic disorder	0.004	0.0157	CbGeAlD
Darifenacin—CHRM3—brain—autistic disorder	0.00358	0.0141	CbGeAlD
Darifenacin—CYP3A4—digestive system—autistic disorder	0.00333	0.0131	CbGeAlD
Darifenacin—CYP2D6—digestive system—autistic disorder	0.00328	0.0129	CbGeAlD
Darifenacin—Fentanyl—OPRM1—autistic disorder	0.00274	0.0626	CrCbGaD
Darifenacin—CYP2D6—head—autistic disorder	0.00267	0.0105	CbGeAlD
Darifenacin—Loperamide—OPRM1—autistic disorder	0.00264	0.0603	CrCbGaD
Darifenacin—Methadone—HTR3A—autistic disorder	0.00262	0.0596	CrCbGaD
Darifenacin—CYP3A4—nervous system—autistic disorder	0.00258	0.0101	CbGeAlD
Darifenacin—CYP2D6—nervous system—autistic disorder	0.00253	0.00996	CbGeAlD
Darifenacin—CYP3A4—central nervous system—autistic disorder	0.00248	0.00974	CbGeAlD
Darifenacin—CYP2D6—central nervous system—autistic disorder	0.00244	0.00959	CbGeAlD
Darifenacin—CYP2D6—cerebellum—autistic disorder	0.00239	0.00937	CbGeAlD
Darifenacin—Clotrimazole—CYP19A1—autistic disorder	0.00227	0.0518	CrCbGaD
Darifenacin—CYP2D6—brain—autistic disorder	0.00194	0.00761	CbGeAlD
Darifenacin—Methadone—OPRM1—autistic disorder	0.00188	0.0429	CrCbGaD
Darifenacin—Methadone—CYP19A1—autistic disorder	0.00133	0.0303	CrCbGaD
Darifenacin—CHRM5—Signaling Pathways—ADRB2—autistic disorder	0.000121	0.000172	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GZMB—autistic disorder	0.00012	0.000171	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GZMB—autistic disorder	0.00012	0.000171	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GZMB—autistic disorder	0.000118	0.000169	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—AVP—autistic disorder	0.000118	0.000169	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—UPB1—autistic disorder	0.000118	0.000169	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IGF2—autistic disorder	0.000118	0.000168	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—OXT—autistic disorder	0.000117	0.000166	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HTR1B—autistic disorder	0.000117	0.000166	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—OXT—autistic disorder	0.000116	0.000166	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR1B—autistic disorder	0.000116	0.000166	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR1B—autistic disorder	0.000115	0.000164	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—OXT—autistic disorder	0.000115	0.000164	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—AVP—autistic disorder	0.000113	0.000162	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IGF2—autistic disorder	0.000113	0.000161	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HTR2A—autistic disorder	0.000112	0.00016	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HTR2A—autistic disorder	0.000112	0.00016	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PLA2G4A—autistic disorder	0.000111	0.000159	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HTR2A—autistic disorder	0.000111	0.000158	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—RORA—autistic disorder	0.000111	0.000158	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ASMT—autistic disorder	0.00011	0.000157	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTM5—autistic disorder	0.00011	0.000157	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PRKCB—autistic disorder	0.000109	0.000155	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL2—autistic disorder	0.000108	0.000155	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MEF2C—autistic disorder	0.000108	0.000154	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DRD1—autistic disorder	0.000108	0.000154	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TSC1—autistic disorder	0.000108	0.000154	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PRKCB—autistic disorder	0.000108	0.000154	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TSC1—autistic disorder	0.000108	0.000154	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DRD1—autistic disorder	0.000108	0.000154	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PRKCB—autistic disorder	0.000107	0.000153	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TSC1—autistic disorder	0.000107	0.000152	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DRD1—autistic disorder	0.000107	0.000152	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PLA2G4A—autistic disorder	0.000107	0.000152	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ITGB3—autistic disorder	0.000106	0.00015	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NTRK2—autistic disorder	0.000105	0.00015	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CYP19A1—autistic disorder	0.000105	0.00015	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NTRK2—autistic disorder	0.000105	0.00015	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DRD3—autistic disorder	0.000105	0.00015	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DRD3—autistic disorder	0.000105	0.000149	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NTRK2—autistic disorder	0.000104	0.000148	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PIK3CG—autistic disorder	0.000104	0.000148	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MAOB—autistic disorder	0.000104	0.000148	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2—autistic disorder	0.000104	0.000148	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MEF2C—autistic disorder	0.000104	0.000148	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PIK3CG—autistic disorder	0.000104	0.000148	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DRD3—autistic disorder	0.000104	0.000148	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC25A12—autistic disorder	0.000103	0.000147	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL5—autistic disorder	0.000103	0.000146	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PIK3CG—autistic disorder	0.000103	0.000146	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL5—autistic disorder	0.000102	0.000146	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CALCA—autistic disorder	0.000101	0.000145	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL5—autistic disorder	0.000101	0.000144	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CALCA—autistic disorder	0.000101	0.000144	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ITGB3—autistic disorder	0.000101	0.000144	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC19A1—autistic disorder	0.000101	0.000143	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CALCA—autistic disorder	0.0001	0.000143	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—POMC—autistic disorder	9.89e-05	0.000141	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PRKCB—autistic disorder	9.86e-05	0.000141	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—POMC—autistic disorder	9.86e-05	0.000141	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HTR2A—autistic disorder	9.86e-05	0.00014	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2—autistic disorder	9.85e-05	0.00014	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PRKCB—autistic disorder	9.83e-05	0.00014	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—COMT—autistic disorder	9.79e-05	0.000139	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—POMC—autistic disorder	9.77e-05	0.000139	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GSTP1—autistic disorder	9.74e-05	0.000139	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PRKCB—autistic disorder	9.74e-05	0.000139	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—MAOA—autistic disorder	9.72e-05	0.000139	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—TPH2—autistic disorder	9.66e-05	0.000138	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—DPYD—autistic disorder	9.5e-05	0.000135	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CAT—autistic disorder	9.48e-05	0.000135	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PIK3CG—autistic disorder	9.44e-05	0.000135	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HTR2A—autistic disorder	9.44e-05	0.000135	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2—autistic disorder	9.43e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PIK3CG—autistic disorder	9.41e-05	0.000134	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TSC2—autistic disorder	9.36e-05	0.000133	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PIK3CG—autistic disorder	9.32e-05	0.000133	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—LEP—autistic disorder	9.16e-05	0.000131	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APOE—autistic disorder	9.16e-05	0.000131	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—POMC—autistic disorder	8.98e-05	0.000128	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TSC2—autistic disorder	8.97e-05	0.000128	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ADSL—autistic disorder	8.96e-05	0.000128	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PRL—autistic disorder	8.96e-05	0.000128	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—POMC—autistic disorder	8.96e-05	0.000128	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PLA2G4A—autistic disorder	8.95e-05	0.000128	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GSTM1—autistic disorder	8.95e-05	0.000128	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PRL—autistic disorder	8.93e-05	0.000127	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—POMC—autistic disorder	8.87e-05	0.000126	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PRL—autistic disorder	8.84e-05	0.000126	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CACNA1C—autistic disorder	8.83e-05	0.000126	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—XDH—autistic disorder	8.79e-05	0.000125	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APOE—autistic disorder	8.77e-05	0.000125	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—LEP—autistic disorder	8.77e-05	0.000125	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PRKCB—autistic disorder	8.64e-05	0.000123	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NPAS2—autistic disorder	8.63e-05	0.000123	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—STX1A—autistic disorder	8.63e-05	0.000123	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GPX1—autistic disorder	8.57e-05	0.000122	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADRB2—autistic disorder	8.5e-05	0.000121	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADRB2—autistic disorder	8.47e-05	0.000121	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADRB2—autistic disorder	8.39e-05	0.00012	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TCN2—autistic disorder	8.33e-05	0.000119	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PRKCB—autistic disorder	8.27e-05	0.000118	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APC—autistic disorder	8.27e-05	0.000118	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CG—autistic disorder	8.27e-05	0.000118	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—EGF—autistic disorder	8.17e-05	0.000116	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—DHFR—autistic disorder	8.04e-05	0.000115	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AVP—autistic disorder	7.99e-05	0.000114	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AVP—autistic disorder	7.96e-05	0.000113	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF2—autistic disorder	7.95e-05	0.000113	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ADA—autistic disorder	7.95e-05	0.000113	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF2—autistic disorder	7.93e-05	0.000113	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APC—autistic disorder	7.92e-05	0.000113	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CG—autistic disorder	7.92e-05	0.000113	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—MTHFR—autistic disorder	7.91e-05	0.000113	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AVP—autistic disorder	7.88e-05	0.000112	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—POMC—autistic disorder	7.87e-05	0.000112	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF2—autistic disorder	7.85e-05	0.000112	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—EGF—autistic disorder	7.83e-05	0.000112	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IGF1—autistic disorder	7.57e-05	0.000108	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—POMC—autistic disorder	7.54e-05	0.000107	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—MAPK1—autistic disorder	7.53e-05	0.000107	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PLA2G4A—autistic disorder	7.51e-05	0.000107	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PLA2G4A—autistic disorder	7.48e-05	0.000107	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PLA2G4A—autistic disorder	7.41e-05	0.000106	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—APOE—autistic disorder	7.36e-05	0.000105	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2—autistic disorder	7.31e-05	0.000104	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MEF2C—autistic disorder	7.3e-05	0.000104	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2—autistic disorder	7.29e-05	0.000104	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MEF2C—autistic disorder	7.28e-05	0.000104	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IGF1—autistic disorder	7.25e-05	0.000103	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—RORA—autistic disorder	7.25e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2—autistic disorder	7.22e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—MAPK1—autistic disorder	7.22e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MEF2C—autistic disorder	7.21e-05	0.000103	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SERPINE1—autistic disorder	7.19e-05	0.000102	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ITGB3—autistic disorder	7.12e-05	0.000101	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ITGB3—autistic disorder	7.1e-05	0.000101	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ITGB3—autistic disorder	7.03e-05	0.0001	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SERPINE1—autistic disorder	6.89e-05	9.81e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MAOB—autistic disorder	6.79e-05	9.68e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CG—autistic disorder	6.65e-05	9.47e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HTR2A—autistic disorder	6.65e-05	9.47e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2—autistic disorder	6.64e-05	9.47e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR2A—autistic disorder	6.62e-05	9.44e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2—autistic disorder	6.62e-05	9.44e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR2A—autistic disorder	6.56e-05	9.35e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2—autistic disorder	6.56e-05	9.34e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—POMC—autistic disorder	6.33e-05	9.02e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TPH2—autistic disorder	6.31e-05	9e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TSC2—autistic disorder	6.31e-05	9e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP19A1—autistic disorder	6.29e-05	8.97e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TSC2—autistic disorder	6.29e-05	8.97e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TSC2—autistic disorder	6.23e-05	8.88e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—DPYD—autistic disorder	6.21e-05	8.85e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—LEP—autistic disorder	6.18e-05	8.81e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOE—autistic disorder	6.18e-05	8.81e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—LEP—autistic disorder	6.16e-05	8.78e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOE—autistic disorder	6.16e-05	8.78e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOE—autistic disorder	6.1e-05	8.69e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—LEP—autistic disorder	6.1e-05	8.69e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HRAS—autistic disorder	6.05e-05	8.62e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—COMT—autistic disorder	5.85e-05	8.34e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PRKCB—autistic disorder	5.83e-05	8.3e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTP1—autistic disorder	5.82e-05	8.3e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2—autistic disorder	5.82e-05	8.29e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MAOA—autistic disorder	5.81e-05	8.28e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PRKCB—autistic disorder	5.81e-05	8.28e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HRAS—autistic disorder	5.79e-05	8.26e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—autistic disorder	5.79e-05	8.25e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CACNA1C—autistic disorder	5.78e-05	8.23e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PRKCB—autistic disorder	5.75e-05	8.2e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAT—autistic disorder	5.67e-05	8.08e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	5.58e-05	7.95e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APC—autistic disorder	5.58e-05	7.95e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2—autistic disorder	5.57e-05	7.94e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APC—autistic disorder	5.56e-05	7.92e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CG—autistic disorder	5.56e-05	7.92e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—autistic disorder	5.54e-05	7.9e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—EGF—autistic disorder	5.51e-05	7.86e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CG—autistic disorder	5.5e-05	7.84e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APC—autistic disorder	5.5e-05	7.84e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—EGF—autistic disorder	5.49e-05	7.83e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PTEN—autistic disorder	5.48e-05	7.8e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—EGF—autistic disorder	5.44e-05	7.75e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PLA2G4A—autistic disorder	5.35e-05	7.63e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTM1—autistic disorder	5.35e-05	7.63e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—POMC—autistic disorder	5.31e-05	7.56e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—POMC—autistic disorder	5.29e-05	7.54e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—DHFR—autistic disorder	5.25e-05	7.49e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTEN—autistic disorder	5.24e-05	7.47e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—POMC—autistic disorder	5.24e-05	7.47e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GPX1—autistic disorder	5.13e-05	7.31e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF1—autistic disorder	5.1e-05	7.28e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF1—autistic disorder	5.09e-05	7.25e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	5.08e-05	7.24e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—MAPK1—autistic disorder	5.06e-05	7.22e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—autistic disorder	5.05e-05	7.19e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF1—autistic disorder	5.04e-05	7.18e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—MAPK1—autistic disorder	5.02e-05	7.15e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	4.85e-05	6.91e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SERPINE1—autistic disorder	4.83e-05	6.89e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SERPINE1—autistic disorder	4.79e-05	6.82e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MTHFR—autistic disorder	4.73e-05	6.74e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK1—autistic disorder	4.45e-05	6.34e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOE—autistic disorder	4.4e-05	6.28e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTEN—autistic disorder	4.4e-05	6.27e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK1—autistic disorder	4.26e-05	6.08e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP19A1—autistic disorder	4.12e-05	5.87e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HRAS—autistic disorder	4.08e-05	5.81e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HRAS—autistic disorder	4.07e-05	5.8e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HRAS—autistic disorder	4.03e-05	5.74e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CG—autistic disorder	3.97e-05	5.66e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2—autistic disorder	3.92e-05	5.59e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2—autistic disorder	3.91e-05	5.57e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—autistic disorder	3.9e-05	5.56e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—autistic disorder	3.89e-05	5.55e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2—autistic disorder	3.87e-05	5.52e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—autistic disorder	3.85e-05	5.49e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—COMT—autistic disorder	3.83e-05	5.45e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTP1—autistic disorder	3.81e-05	5.43e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MAOA—autistic disorder	3.8e-05	5.41e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—POMC—autistic disorder	3.78e-05	5.39e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAT—autistic disorder	3.71e-05	5.28e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTEN—autistic disorder	3.69e-05	5.26e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTEN—autistic disorder	3.68e-05	5.25e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTEN—autistic disorder	3.64e-05	5.19e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HRAS—autistic disorder	3.57e-05	5.09e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PLA2G4A—autistic disorder	3.5e-05	4.99e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTM1—autistic disorder	3.5e-05	4.99e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HRAS—autistic disorder	3.42e-05	4.88e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—autistic disorder	3.42e-05	4.87e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GPX1—autistic disorder	3.35e-05	4.78e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—autistic disorder	3.28e-05	4.67e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MTHFR—autistic disorder	3.09e-05	4.41e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—autistic disorder	3.02e-05	4.3e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK1—autistic disorder	3e-05	4.28e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK1—autistic disorder	2.99e-05	4.26e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK1—autistic disorder	2.96e-05	4.22e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOE—autistic disorder	2.88e-05	4.1e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTEN—autistic disorder	2.63e-05	3.75e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.6e-05	3.7e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—POMC—autistic disorder	2.47e-05	3.53e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HRAS—autistic disorder	2.41e-05	3.43e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HRAS—autistic disorder	2.4e-05	3.42e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HRAS—autistic disorder	2.38e-05	3.39e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—autistic disorder	2.31e-05	3.29e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—autistic disorder	2.3e-05	3.28e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—autistic disorder	2.28e-05	3.24e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—autistic disorder	1.97e-05	2.81e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTEN—autistic disorder	1.72e-05	2.45e-05	CbGpPWpGaD
